133 related articles for article (PubMed ID: 8077723)
1. Risk factors for invasive fungal infections complicating orthotopic liver transplantation.
Collins LA; Samore MH; Roberts MS; Luzzati R; Jenkins RL; Lewis WD; Karchmer AW
J Infect Dis; 1994 Sep; 170(3):644-52. PubMed ID: 8077723
[TBL] [Abstract][Full Text] [Related]
2. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
Hadley S; Samore MH; Lewis WD; Jenkins RL; Karchmer AW; Hammer SM
Transplantation; 1995 Mar; 59(6):851-9. PubMed ID: 7535482
[TBL] [Abstract][Full Text] [Related]
3. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for invasive aspergillosis in liver transplant recipients.
Fortún J; Martín-Dávila P; Moreno S; De Vicente E; Nuño J; Candelas A; Bárcena R; García M
Liver Transpl; 2002 Nov; 8(11):1065-70. PubMed ID: 12424722
[TBL] [Abstract][Full Text] [Related]
5. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.
Badiee P; Kordbacheh P; Alborzi A; Malekhoseini S; Zeini F; Mirhendi H; Mahmoodi M
Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362
[TBL] [Abstract][Full Text] [Related]
6. Invasive aspergillosis in the recipients of liver retransplantation.
Singh N; Pruett TL; Houston S; Muñoz P; Cacciarelli TV; Wagener MM; Husain S
Liver Transpl; 2006 Aug; 12(8):1205-9. PubMed ID: 16598780
[TBL] [Abstract][Full Text] [Related]
7. Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome.
Benedetti E; Gruessner AC; Troppmann C; Papalois BE; Sutherland DE; Dunn DL; Gruessner RW
J Am Coll Surg; 1996 Oct; 183(4):307-16. PubMed ID: 8843258
[TBL] [Abstract][Full Text] [Related]
8. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.
Husain S; Tollemar J; Dominguez EA; Baumgarten K; Humar A; Paterson DL; Wagener MM; Kusne S; Singh N
Transplantation; 2003 Jun; 75(12):2023-9. PubMed ID: 12829905
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
[TBL] [Abstract][Full Text] [Related]
10. [Invasive mycoses in liver transplantation].
Romanyk J; del Palacio A; Fiaño C; Lumbreras C; Cuétara S; Moreno P; Sánchez-Rivas JL
Enferm Infecc Microbiol Clin; 1991; 9(6):323-8. PubMed ID: 1932238
[TBL] [Abstract][Full Text] [Related]
11. Association of hepatic iron overload with invasive fungal infection in liver transplant recipients.
Alexander J; Limaye AP; Ko CW; Bronner MP; Kowdley KV
Liver Transpl; 2006 Dec; 12(12):1799-804. PubMed ID: 16741903
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
[TBL] [Abstract][Full Text] [Related]
13. A model to predict survival following liver retransplantation.
Rosen HR; Madden JP; Martin P
Hepatology; 1999 Feb; 29(2):365-70. PubMed ID: 9918911
[TBL] [Abstract][Full Text] [Related]
14. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with long-term survival following cardiac transplantation.
Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
[TBL] [Abstract][Full Text] [Related]
16. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients.
Fortún J; Martín-Davila P; Moreno S; Barcena R; de Vicente E; Honrubia A; García M; Nuño J; Candela A; Uriarte M; Pintado V
J Antimicrob Chemother; 2003 Nov; 52(5):813-9. PubMed ID: 14563893
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
Weiss ES; Nwakanma LU; Patel ND; Yuh DD
J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
[TBL] [Abstract][Full Text] [Related]
18. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function.
Emre S; Gondolesi G; Polat K; Ben-Haim M; Artis T; Fishbein TM; Sheiner PA; Kim-Schluger L; Schwartz ME; Miller CM
Liver Transpl; 2001 Mar; 7(3):220-5. PubMed ID: 11244163
[TBL] [Abstract][Full Text] [Related]
19. Management of fungal colonization and infection after living donor liver transplantation.
Yamanouchi K; Eguchi S; Takatsuki M; Hidaka M; Kamohara Y; Miyazaki K; Hamasaki K; Tajima Y; Kanematsu T
Hepatogastroenterology; 2010; 57(101):852-7. PubMed ID: 21033241
[TBL] [Abstract][Full Text] [Related]
20. Aspergillus infections in lung transplant recipients: risk factors and outcome.
Solé A; Morant P; Salavert M; Pemán J; Morales P;
Clin Microbiol Infect; 2005 May; 11(5):359-65. PubMed ID: 15819861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
